{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:38:42Z","timestamp":1782229122216,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00259-016-3508-0","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T14:39:21Z","timestamp":1473431961000},"page":"408-416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Influence of blood-brain barrier permeability on O-(2-18F-fluoroethyl)-L-tyrosine uptake in rat gliomas"],"prefix":"10.1007","volume":"44","author":[{"given":"Carina","family":"Stegmayr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Bandelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Lohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Willuweit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Filss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Galldiks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim H. R.","family":"L\u00fcbke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Jon","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Ermert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Josef","family":"Langen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,9]]},"reference":[{"key":"3508_CR1","first-page":"70","volume":"59","author":"N Galldiks","year":"2015","unstructured":"Galldiks N, Langen KJ. Applications of PET imaging of neurological tumors with radiolabeled amino acids. Q J Nucl Med Mol Imaging. 2015;59:70\u201382.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"3508_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1053\/j.semnuclmed.2012.06.001","volume":"42","author":"K Herholz","year":"2012","unstructured":"Herholz K, Langen KJ, Schiepers C, Mountz JM. Brain tumors. Semin Nucl Med. 2012;42:356\u201370. doi: 10.1053\/j.semnuclmed.2012.06.001 .","journal-title":"Semin Nucl Med"},{"key":"3508_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.nucmedbio.2006.01.002","volume":"33","author":"KJ Langen","year":"2006","unstructured":"Langen KJ, Hamacher K, Weckesser M, Floeth F, Stoffels G, Bauer D, et al. O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol. 2006;33:287\u201394. doi: 10.1016\/j.nucmedbio.2006.01.002 .","journal-title":"Nucl Med Biol"},{"key":"3508_CR4","first-page":"205","volume":"40","author":"HJ Wester","year":"1999","unstructured":"Wester HJ, Herz M, Weber W, Heiss P, Senekowitsch-Schmidtke R, Schwaiger M, et al. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med: Off Publ, Soc Nucl Med. 1999;40:205\u201312.","journal-title":"J Nucl Med: Off Publ, Soc Nucl Med"},{"key":"3508_CR5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/neuonc\/nov088","volume":"17","author":"N Galldiks","year":"2015","unstructured":"Galldiks N, Stoffels G, Filss C, Rapp M, Blau T, Tscherpel C, et al. The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma. Neuro-Oncology. 2015;17:1293\u2013300. doi: 10.1093\/neuonc\/nov088 .","journal-title":"Neuro-Oncology"},{"key":"3508_CR6","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2967\/jnumed.111.098590","volume":"53","author":"N Galldiks","year":"2012","unstructured":"Galldiks N, Langen K, Holy R, Pinkawa M, Stoffels G, Nolte K, et al. Assessment of treatment response in patients with glioblastoma using [18F]Fluoroethyl-L-Tyrosine PET in comparison to MRI. J Nucl Med: Off Publ, Soc Nucl Med. 2012;53:1048\u201357.","journal-title":"J Nucl Med: Off Publ, Soc Nucl Med"},{"key":"3508_CR7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/brain\/awh399","volume":"128","author":"D Pauleit","year":"2005","unstructured":"Pauleit D, Floeth F, Hamacher K, Riemenschneider MJ, Reifenberger G, Muller HW, et al. O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain: J Neurol. 2005;128:678\u201387. doi: 10.1093\/brain\/awh399 .","journal-title":"Brain: J Neurol"},{"key":"3508_CR8","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.nucmedbio.2009.05.005","volume":"36","author":"D Pauleit","year":"2009","unstructured":"Pauleit D, Stoffels G, Bachofner A, Floeth FW, Sabel M, Herzog H, et al. Comparison of (18)F-FET and (18)F-FDG PET in brain tumors. Nucl Med Biol. 2009;36:779\u201387. doi: 10.1016\/j.nucmedbio.2009.05.005 .","journal-title":"Nucl Med Biol"},{"key":"3508_CR9","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00259-010-1457-6","volume":"37","author":"R Pichler","year":"2010","unstructured":"Pichler R, Dunzinger A, Wurm G, Pichler J, Weis S, Nussbaumer K, et al. Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance? Eur J Nucl Med Mol Imaging. 2010;37:1521\u20138. doi: 10.1007\/s00259-010-1457-6 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3508_CR10","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s00259-004-1590-1","volume":"31","author":"G Popperl","year":"2004","unstructured":"Popperl G, Gotz C, Rachinger W, Gildehaus FJ, Tonn JC, Tatsch K. Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging. 2004;31:1464\u201370. doi: 10.1007\/s00259-004-1590-1 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3508_CR11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2967\/jnumed.106.037895","volume":"48","author":"FW Floeth","year":"2007","unstructured":"Floeth FW, Pauleit D, Sabel M, Stoffels G, Reifenberger G, Riemenschneider MJ, et al. Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma. J Nucl Med: Off Publ, Soc Nucl Med. 2007;48:519\u201327.","journal-title":"J Nucl Med: Off Publ, Soc Nucl Med"},{"key":"3508_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2967\/jnumed.114.144675","volume":"56","author":"NL Jansen","year":"2015","unstructured":"Jansen NL, Suchorska B, Wenter V, Schmid-Tannwald C, Todica A, Eigenbrod S, et al. Prognostic Significance of Dynamic 18F-FET PET in Newly Diagnosed Astrocytic High-Grade Glioma. J Nucl Med: Off Publ, Soc Nucl Med. 2015;56:9\u201315. doi: 10.2967\/jnumed.114.144675 .","journal-title":"J Nucl Med: Off Publ, Soc Nucl Med"},{"key":"3508_CR13","first-page":"393","volume":"47","author":"G Popperl","year":"2006","unstructured":"Popperl G, Kreth FW, Herms J, Koch W, Mehrkens JH, Gildehaus FJ, et al. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J Nucl Med: Off Publ, Soc Nucl Med. 2006;47:393\u2013403.","journal-title":"J Nucl Med: Off Publ, Soc Nucl Med"},{"key":"3508_CR14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00259-004-1705-8","volume":"32","author":"M Weckesser","year":"2005","unstructured":"Weckesser M, Langen KJ, Rickert CH, Kloska S, Straeter R, Hamacher K, et al. O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging. 2005;32:422\u20139. doi: 10.1007\/s00259-004-1705-8 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3508_CR15","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s00259-007-0534-y","volume":"34","author":"G Popperl","year":"2007","unstructured":"Popperl G, Kreth FW, Mehrkens JH, Herms J, Seelos K, Koch W, et al. FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading. Eur J Nucl Med Mol Imaging. 2007;34:1933\u201342. doi: 10.1007\/s00259-007-0534-y .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3508_CR16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/RLU.0b013e3182291b40","volume":"36","author":"ML Calcagni","year":"2011","unstructured":"Calcagni ML, Galli G, Giordano A, Taralli S, Anile C, Niesen A, et al. Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy. Clin Nucl Med. 2011;36:841\u20137. doi: 10.1097\/RLU.0b013e3182291b40 .","journal-title":"Clin Nucl Med"},{"key":"3508_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00726-014-1863-3","volume":"47","author":"A Habermeier","year":"2015","unstructured":"Habermeier A, Graf J, Sandhofer BF, Boissel JP, Roesch F, Closs EI. System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET). Amino Acids. 2015;47:335\u201344. doi: 10.1007\/s00726-014-1863-3 .","journal-title":"Amino Acids"},{"key":"3508_CR18","doi-asserted-by":"publisher","first-page":"e100009","DOI":"10.1371\/journal.pone.0100009","volume":"9","author":"MK Nedergaard","year":"2014","unstructured":"Nedergaard MK, Kristoffersen K, Michaelsen SR, Madsen J, Poulsen HS, Stockhausen MT, et al. The use of longitudinal 18F-FET MicroPET imaging to evaluate response to irinotecan in orthotopic human glioblastoma multiforme xenografts. PLoS One. 2014;9:e100009. doi: 10.1371\/journal.pone.0100009 .","journal-title":"PLoS One"},{"key":"3508_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/neuonc\/noq196","volume":"13","author":"M Kunz","year":"2011","unstructured":"Kunz M, Thon N, Eigenbrod S, Hartmann C, Egensperger R, Herms J, et al. Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas. Neuro-Oncology. 2011;13:307\u201316. doi: 10.1093\/neuonc\/noq196 .","journal-title":"Neuro-Oncology"},{"key":"3508_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/neuonc\/nos300","volume":"15","author":"M Hutterer","year":"2013","unstructured":"Hutterer M, Nowosielski M, Putzer D, Jansen NL, Seiz M, Schocke M, et al. [F-18]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma. Neuro-Oncol. 2013;15:341\u201351. doi: 10.1093\/neuonc\/nos300 .","journal-title":"Neuro-Oncol."},{"key":"3508_CR21","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/neuonc\/not059","volume":"15","author":"KJ Langen","year":"2013","unstructured":"Langen KJ, Galldiks N. Reply to \"[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma\" by Hutterer et al. Neuro-Oncology. 2013;15:816\u20137. doi: 10.1093\/neuonc\/not059 .","journal-title":"Neuro-Oncology"},{"key":"3508_CR22","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1227\/NEU.0b013e3181fa775b","volume":"67","author":"C Kotsarini","year":"2010","unstructured":"Kotsarini C, Griffiths PD, Wilkinson ID, Hoggard N. A systematic review of the literature on the effects of dexamethasone on the brain from in vivo human-based studies: implications for physiological brain imaging of patients with intracranial tumors. Neurosurgery. 2010;67:1799\u2013815. doi: 10.1227\/NEU.0b013e3181fa775b . discussion 815.","journal-title":"Neurosurgery"},{"key":"3508_CR23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(03)00410-1","volume":"2","author":"R Sarin","year":"2003","unstructured":"Sarin R, Murthy V. Medical decompressive therapy for primary and metastatic intracranial tumours. Lancet Neurol. 2003;2:357\u201365.","journal-title":"Lancet Neurol"},{"key":"3508_CR24","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00259-015-3274-4","volume":"43","author":"C Stegmayr","year":"2016","unstructured":"Stegmayr C, Schoneck M, Oliveira D, Willuweit A, Filss C, Galldiks N, et al. Reproducibility of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas. Eur J Nucl Med Mol Imaging. 2016;43:1115\u201323. doi: 10.1007\/s00259-015-3274-4 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3508_CR25","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.nucmedbio.2013.05.001","volume":"40","author":"MD Piroth","year":"2013","unstructured":"Piroth MD, Prasath J, Willuweit A, Stoffels G, Sellhaus B, van Osterhout A, et al. Uptake of O-(2-[18F]fluoroethyl)-L-tyrosine in reactive astrocytosis in the vicinity of cerebral gliomas. Nucl Med Biol. 2013;40:795\u2013800. doi: 10.1016\/j.nucmedbio.2013.05.001 .","journal-title":"Nucl Med Biol"},{"key":"3508_CR26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0969-8051(03)00023-4","volume":"30","author":"KJ Langen","year":"2003","unstructured":"Langen KJ, Jarosch M, Muhlensiepen H, Hamacher K, Broer S, Jansen P, et al. Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas. Nucl Med Biol. 2003;30:501\u20138.","journal-title":"Nucl Med Biol"},{"key":"3508_CR27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2967\/jnumed.108.056374","volume":"50","author":"Q Bao","year":"2009","unstructured":"Bao Q, Newport D, Chen M, Stout DB, Chatziioannou AF. Performance evaluation of the inveon dedicated PET preclinical tomograph based on the NEMA NU-4 standards. J Nucl Med: Off Publ, Soc Nucl Med. 2009;50:401\u20138. doi: 10.2967\/jnumed.108.056374 .","journal-title":"J Nucl Med: Off Publ, Soc Nucl Med"},{"key":"3508_CR28","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0969-8043(02)00225-7","volume":"57","author":"K Hamacher","year":"2002","unstructured":"Hamacher K, Coenen HH. Efficient routine production of the 18F-labelled amino acid O-2-18F fluoroethyl-L-tyrosine. Appl Radiat Isot : Incl Data, Instrum Methods for Use in Agric, Ind Med. 2002;57:853\u20136.","journal-title":"Appl Radiat Isot : Incl Data, Instrum Methods for Use in Agric, Ind Med"},{"key":"3508_CR29","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010;28:1963\u201372. doi: 10.1200\/JCO.2009.26.3541 .","journal-title":"J Clin Oncol"},{"key":"3508_CR30","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00259-014-2959-4","volume":"42","author":"N Galldiks","year":"2015","unstructured":"Galldiks N, Dunkl V, Stoffels G, Hutterer M, Rapp M, Sabel M, et al. Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET. Eur J Nucl Med Mol Imaging. 2015;42:685\u201395. doi: 10.1007\/s00259-014-2959-4 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3508_CR31","first-page":"1931","volume":"45","author":"N Spaeth","year":"2004","unstructured":"Spaeth N, Wyss MT, Weber B, Scheidegger S, Lutz A, Verwey J, et al. Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence. J Nucl Med: Off Publ, Soc Nucl Med. 2004;45:1931\u20138.","journal-title":"J Nucl Med: Off Publ, Soc Nucl Med"},{"key":"3508_CR32","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/jcbfm.1988.59","volume":"8","author":"O Uyama","year":"1988","unstructured":"Uyama O, Okamura N, Yanase M, Narita M, Kawabata K, Sugita M. Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab. 1988;8:282\u20134. doi: 10.1038\/jcbfm.1988.59 .","journal-title":"J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab"},{"key":"3508_CR33","doi-asserted-by":"publisher","first-page":"e68595","DOI":"10.1371\/journal.pone.0068595","volume":"8","author":"LF Yen","year":"2013","unstructured":"Yen LF, Wei VC, Kuo EY, Lai TW. Distinct patterns of cerebral extravasation by Evans blue and sodium fluorescein in rats. PLoS One. 2013;8:e68595. doi: 10.1371\/journal.pone.0068595 .","journal-title":"PLoS One"},{"key":"3508_CR34","doi-asserted-by":"publisher","first-page":"e16621","DOI":"10.1371\/journal.pone.0016621","volume":"6","author":"MM Darpolor","year":"2011","unstructured":"Darpolor MM, Molthen RC, Schmainda KM. Multimodality imaging of abnormal vascular perfusion and morphology in preclinical 9L gliosarcoma model. PLoS One. 2011;6:e16621. doi: 10.1371\/journal.pone.0016621 .","journal-title":"PLoS One"},{"key":"3508_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1215\/S1152851703000073","volume":"5","author":"MA Badruddoja","year":"2003","unstructured":"Badruddoja MA, Krouwer HG, Rand SD, Rebro KJ, Pathak AP, Schmainda KM. Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. Neuro-Oncology. 2003;5:235\u201343. doi: 10.1215\/S1152851703000073 .","journal-title":"Neuro-Oncology"},{"key":"3508_CR36","doi-asserted-by":"publisher","unstructured":"Saunders NR, Dziegielewska KM, Mollgard K, Habgood MD. Markers for blood-brain barrier integrity: how appropriate is Evans blue in the twenty-first century and what are the alternatives? Front Neurosci. 2015;9:385. doi: 10.3389\/fnins.2015.00385 .","DOI":"10.3389\/fnins.2015.00385"},{"key":"3508_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2013.10.028","author":"B Yu","year":"2013","unstructured":"Yu B, Ruan M, Dong X, Yu Y, Cheng H. The mechanism of the opening of the blood-brain barrier by borneol: A pharmacodynamics and pharmacokinetics combination study. J Ethnopharmacol. 2013. doi: 10.1016\/j.jep.2013.10.028 .","journal-title":"J Ethnopharmacol"},{"key":"3508_CR38","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s11011-014-9609-1","volume":"30","author":"Z Li","year":"2015","unstructured":"Li Z, Liang G, Ma T, Li J, Wang P, Liu L, et al. Blood-brain barrier permeability change and regulation mechanism after subarachnoid hemorrhage. Metab Brain Dis. 2015;30:597\u2013603. doi: 10.1007\/s11011-014-9609-1 .","journal-title":"Metab Brain Dis"},{"key":"3508_CR39","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1097\/WNR.0000000000000464","volume":"26","author":"Y Fan","year":"2015","unstructured":"Fan Y, Yang X, Tao Y, Lan L, Zheng L, Sun J. Tight junction disruption of blood-brain barrier in white matter lesions in chronic hypertensive rats. Neuroreport. 2015;26:1039\u201343. doi: 10.1097\/WNR.0000000000000464 .","journal-title":"Neuroreport"},{"key":"3508_CR40","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1083\/jcb.40.3.648","volume":"40","author":"MW Brightman","year":"1969","unstructured":"Brightman MW, Reese TS. Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol. 1969;40:648\u201377.","journal-title":"J Cell Biol"},{"key":"3508_CR41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1083\/jcb.34.1.207","volume":"34","author":"TS Reese","year":"1967","unstructured":"Reese TS, Karnovsky MJ. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol. 1967;34:207\u201317.","journal-title":"J Cell Biol"},{"key":"3508_CR42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s004010000180","volume":"100","author":"S Liebner","year":"2000","unstructured":"Liebner S, Fischmann A, Rascher G, Duffner F, Grote EH, Kalbacher H, et al. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol. 2000;100:323\u201331.","journal-title":"Acta Neuropathol"},{"key":"3508_CR43","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1083\/jcb.200302070","volume":"161","author":"T Nitta","year":"2003","unstructured":"Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol. 2003;161:653\u201360. doi: 10.1083\/jcb.200302070 .","journal-title":"J Cell Biol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3508-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-016-3508-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3508-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:21:56Z","timestamp":1498342916000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-016-3508-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["3508"],"URL":"https:\/\/doi.org\/10.1007\/s00259-016-3508-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,9]]}}}